Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care
Lyn Kleinbach-Reilly/LinkedIn
Aug 31, 2026, 13:38

Lyn Kleinbach-Reilly: A New Standard for Coagulation Testing in Neonatal Care

Lyn Kleinbach-Reilly, Co-Founder and Principal at FurEver Talent Partners, Founder and Lead Recruiter at TKG, shared a post on LinkedIn:

“Every NICU in the country is using an adult coagulation test on newborns.

That’s not a knock on clinicians – the tools they’re using were built for adults, not for a 900-gram preterm infant with barely enough blood volume to test in the first place.

This company built the first point-of-care coagulation device actually designed for neonates.

Their device tests native blood – no chemical stabilizers – using a fraction of the sample volume older platforms like TEG and ROTEM require.

It holds FDA breakthrough device designation for assessing coagulation in preterm and full-term babies.

This is the rare kind of opportunity in medtech sales: the clinical need already exists in these NICUs, and the product is a genuine step forward, not a hard sell for a ‘maybe’.

These are three senior, strategic sales roles – East, Midwest, and West – not script-and-quota gigs.

Well-funded.

Led by a CEO with deep Abbott experience.

This is a ground-floor seat: the chance to use your strategic experience to build out your own territory and business, with direct access to a CEO who’s done this before.”

Stay updated with Hemostasis Today.

Coagulation Test FDA Health Hematology Hemostasis Hemostasis News Hemostasis Today Lyn Kleinbach-Reilly Medicine NICU platelets ROTEM TEG
NewsFeed